Common Contracts
3 similar null contracts by Xenetic Biosciences, Inc., NXT-Id, Inc.
COMMON STOCK PURCHASE WARRANT Nxt-ID, Inc.NXT-Id, Inc. • May 30th, 2018 • Services-detective, guard & armored car services • New York
This Warrant is issued pursuant to that certain Senior Secured Credit Agreement, dated as of May 24, 2018 (the “Credit Agreement”) by and among LogicMark, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company, as borrower, the lenders from time to time party thereto, and Sagard Holdings Manager LP, as administrative agent and collateral agent for the lenders.
FORM OF COMMON STOCK PURCHASE WARRANT XENETIC BIOSCIENCES, INC.Xenetic Biosciences, Inc. • November 16th, 2015 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________]or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March 31, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Issue Date written above (the “Termination Date”) but not thereafter, to subscribe for and purchase from Xenetic Biosciences, Inc., a Nevada corporation (the “Company”), up to 1,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
FORM OF COMMON STOCK PURCHASE WARRANT XENETIC BIOSCIENCES, INC.Xenetic Biosciences, Inc. • November 16th, 2015 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, OJSC Pharmsynthez or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the earlier to occur of March 31, 2016 and the Measurement Date (as that term is defined in that certain Asset Purchase Agreement, dated as of November [__], 2015, as amended, among AS Kevelt, Holder, the Company and Lipoxen Technologies, Ltd.)(the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Issue Date written above (the “Termination Date”) but not thereafter, to subscribe for and purchase from Xenetic Biosciences, Inc., a Nevada corporation (the “Company”), up to 10,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price
